I can’t be the only person who finds it annoying how difficult it is to compare and understand the health care costs of cancer treatment. Why should you know? To be prepared. If you are on Medicare, you want to know so you understand what is your responsibility and what’s theirs. If you are underinsured or uninsured, understanding the costs can help you negotiate.
There's a government agency that has cost data by Medicare procedure code. Also try Medicare, and if they don't compile that information, they should be able to refer to you to the agency that does. If you can find out the Medicare procedure code for the ones you want to check, you can then go to this tool doctors use to check Medicare reimbursements:
https://catalog.ama-assn.org/Catalog/cpt/cpt_search.jsp?_DARGS=/Catalog/...
Also costs for procedures on a state-by-state basis are here: http://www.nlm.nih.gov/services/procedcosts.html
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...